P1.035. Postoperative Acid-Suppressive Therapy Duration and Risk Factor of Gastroesophageal Reflux Disease Following Subtotal Esophagectomy

Clicks: 20
ID: 326162
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #206 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Benign Disease: Iatrogenic Esophageal Disease, Perforation and Postsurgical Complications Background Gastroesophageal reflux disease (GERD) after esophagectomy is an important complication that impairs postoperative quality of life (QOL). However, factors associated with the incidence of GERD, particularly the impact of acid-suppressive medication use, remain unclear. Methods We retrospectively analyzed 106 patients who underwent esophagectomy for esophageal cancer at our institution between January 2013 and December 2022. GERD was defined as the presence of reflux symptoms persisting for more than three months postoperatively or endoscopic findings of GERD graded as Los Angeles classification grade A or higher. The associations between perioperative factors and the development of GERD were evaluated. Multivariable analysis using competing risk regression was used for analysis. Results During a median follow-up period of 52.1 months, the 3-year cumulative incidence of GERD was 34.3%. All patients received postoperative acid-suppressive therapy, with a median treatment duration of 33.8 months (0.83–105.7). Sixteen patients discontinued therapy within one year, whereas 90 patients continued therapy for ≥1 year. No significant difference in GERD incidence was observed among medication types. Multivariable analysis demonstrated that discontinuation of acid-suppressive medication within one year after surgery was independently associated with the development of GERD. Sex, age, preoperative body mass index, Brinkman index, postoperative body weight change, anastomotic stricture, and recurrent laryngeal nerve palsy were not significantly associated with GERD. Conclusion Continuation of acid-suppressive therapy for at least one year after esophagectomy may help reduce the incidence of postoperative GERD. The optimal duration of acid-suppressive therapy after esophagectomy remains unclear and requires further investigation.
Reference Key
openalex_W7203976080 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yoshihisa Numata, Tomoyuki Okumura, Takeshi Miwa, T Araki, Masakazu Nagamori, Naoya Takeda, Toru Watanabe, Shinichi Sekine, Isaya Hashimoto, Tsutomu Fujii
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.183
URL
https://doi.org/10.1093/dote/doag077.183
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.